Jagsonpal Pharmaceuticals Limited
2,671words
4turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
23%
₹756
₹157
21%
rs 2
₹108
23.1%
24.1%
17 bps
562 bps
20.8%
Guidance — 8 items
Mumbai Office
opening
“We expect the growth momentum to continue as we deepen our presence in the domestic pharmaceutical market coupled with prudent use of free cash to look for a strategically suitable inorganic opportunity.”
Mumbai Office
opening
“Manish Gupta Managing Director We expect the growth momentum to continue as we deepen our presence in the domestic pharmaceutical market coupled with prudent use of free cash to look for a strategically suitable inorganic opportunity.”
Mumbai Office
opening
“On course to meet annual guidance Remains dedicated to innovation driven strategy coupled with strong inorganic capabilities along the way.”
Mumbai Office
opening
“9.4% 27.8% Revenue CAGR (FY21-25) EBITDA CAGR (FY21-25) 33.8% PAT CAGR (FY21-25) INR 1609 Mn Cash Balance as on Jun’25.”
Mumbai Office
opening
“23% & 50% ROCE & ROE (FY25) 13 Days NWCC (FY25) down from 56 days in FY22 1.”
Mumbai Office
opening
“1-2 New Product Launches Every Quarter o Focus On Mid-Sized, Sub Chronic Segment o Aim For Substantial Market Share In Niche Segment Research & Development Contract Manufacturing o Partner with leading CDMO players for product research and development o Partner with leading Indian CMO for manufacturing ~i~ lliiiiiiii' PAN-India Distribution o 1000+ Medical Reps for brand promotion o 18 stocking points across the country to ensure last- mile delivery 12 Strategic Pillars UAGSONPAL!”
Lean Operations
opening
“I i i j ~--·-·-·-·-·-·-·· FY25 3.5% 93 I / 34% 14% 28% ----- 14% 60% 57% 17% ---- 12% FY21 FY22 FY23 FY24 50% r·-·-·-·-·-·-·-·• • i I • • I !”
Lean Operations
opening
“i • I j I ~--·-·-·-·-·-·-·~ FY25 NWC (Rs.Mn) % of Sales ROE ROCE • Freeing up capital from operations to invest in growth • Robust cash flows enabling higher distributions.”
Speaking time
1
1
1
1
Opening remarks
Ph.
www.jagsonpal.com A CSR Initiative y -i akht UAGSONPAL! July 26, 2025 The Department of Corporate Services- Listing BSE Ltd, Phiroze Jeejeebhoy Towers, Dalal Street Mumbai-400 001 Scrip Code: 507789 The Department of Corporate Services- Listing National Stock Exchange of India Ltd Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai – 400 051 Symbol: JAGSNPHARM Subject: Revised Investor Presentation on Unaudited Financial Results for quarter ended June 30, 2025 Dear Sir/ Madam, Further, to our earlier communication dated July 26, 2025, regarding the Investor Presentation for the Unaudited Financial Results for the quarter ended June 30, 2025, we wish to inform you that an inadvertent error was identified on pages 10 and 11 of the presentation. The enclosed revised Investor Presentation incorporates the necessary corrections to rectify the said error. We request you to kindly take the revised presentation on record and oblige. Thanking you, For Jagsonpal Pharmaceuticals
Mumbai Office
13-14, Unit 3B, Phoenix Paragon Plaza, Kurla West, Mumbai, Maharashtra- 400070 Jagsonpal Pharmaceuticals announces Q1FY26 Results Q1FY26 Revenue up 23% YoY to ₹756 Mn, EBITDA at ₹157 Mn with 21% margin; PAT soars 2x to ₹108 Mn. Gurugram, July 26, 2025: Jagsonpal Pharmaceuticals Limited (BSE: 507789, NSE: JAGSNPHARM) today announced the unaudited financial results for the quarter ended June 30, 2025. Rs. in Mn Q1FY26 Q1FY25 YoY % Q4FY25 QoQ % 23.1% Revenue 24.1% Operating EBITDA* 17 bps EBITDA Margin* (38.9) % ESOP Cost 562 bps PAT *Operating EBITDA and EBITDA margins before ESOP accounting 756 157 20.8% 15 108 614 127 20.6% 24 53 586 97 16.6% 10 66 29.1% 61.9% 420 bps 50.3% 300 bps Q1FY26 Key Highlights: Strong Growth Momentum in Q1FY26: Reported a 23.1% YoY surge in revenue to Rs. 756 Mn, powered by sustained performance across its key brands. The company’s focused brand-building strategy continued to yield results, enhancing market presence. Margins Expand on Brand Strength, Prof
Lean Operations
Asset Light Model Inorganic Growth Powered by Strategic Acquisition 13 MySakhi Initiative: Where Business Meets Social Impact Real World Impact: Beyond The Bottom Line Shaping the Future Expanding outreach with self-testing kits, discounted lab tests, and an online forum to support women’s holistic well- being. Driving Menopause Awareness Deliver impactful virtual sessions on menopause, supported by social media campaigns and community engagement. Empowering Women Through MySakhi.in A dedicated website offering educational resources, health tools, and community support focused on women's health Transforming Hygiene Access Built modern sanitation complexes across Punjab, Haryana, and Uttarakhand, fostering health and dignity for schoolgirls. 1':::jll 1.:,. 0 00 ffl 20 5-Year journey in a nutshell Revenue (Rs Mn) 2,176 2,367 2,087 1,879 I"'·-·-·-·-·-·, 2,687 FY21 FY22 FY23 FY24 PAT (Rs Mn) FY25 L--•-•-•-•-•.J I"'·-·-·-·-·-·, 375 171 189 267 225 HJAGSONPAL (All values in ₹ Mn) 579 Operati